Pharmacy Benefit Management

From Drug Benefit News - As health plans and PBMs consider how to address manufacturer-offered copay cards and other discounts on brand-name drugs — whether by encouraging their use among members, blocking the coupons or taking a more targeted approach — payers should keep a close watch on pharmaceutical manufacturers’ attempts to refine these programs to match competitors and gain market share. Read more

From Drug Benefit News - While this year’s 2015 Advance Notice issued by CMS on Feb. 21 contained a number of negative surprises for Medicare Advantage plans — including proposed changes that would lower MA plans’ base payment rates — the draft Call Letter portion of the document featured more minor tweaks to the Part D program and provisions that were already expected, like the termination of consistently low-performing plans. Read more

Pharmacy Benefit Management Blog

By Angela Maas - April 7, 2014
Lately it seems like everyone has been weighing in with their outrage over the $1,000 per day hepatitis C treatment Sovaldi. That price translates to $84,000 for a 12-week treatment regimen and $168,000 for a 24-week cycle — certainly not an inexpensive proposition. But what seems to be lost in...
By Lauren Flynn Kelly - April 4, 2014
In a recent pharmacy benefit update to its broker website, UnitedHealthcare unveiled a new tactic to block pharmaceutical manufacturer-offered copay coupons, which the insurer and many of its peers argue undermine payers’ formulary designs and raise drug costs. Unlike previously reported methods...
By AIS Staff - March 27, 2014
Last week’s issue of Drug Benefit News (DBN) spotlighted a new report from Express Scripts finding that the use of ADHD medications is rising among all adults, but especially women. According to the new report, Turning Attention to ADHD: U.S. Medication Trends for Attention Deficit Hyperactivity...

It's quick and easy to sign up for FREE access to!

Why do I need to register?